Stay updated on UNCOVER-1 Psoriasis Treatment Clinical Trial
Sign up to get notified when there's something new on the UNCOVER-1 Psoriasis Treatment Clinical Trial page.

Latest updates to the UNCOVER-1 Psoriasis Treatment Clinical Trial page
- Check4 days agoChange DetectedThe record provides detailed information about the completed Phase 3 UNCOVER-1 psoriasis study, including its ixekizumab treatment arms, participant criteria, study outcomes, locations, and publications.SummaryDifference96%

- Check11 days agoChange DetectedThe site footer now identifies ClinicalTrials.gov as revision v3.8.0 instead of v3.7.2, while the study record remains behind a 403 Forbidden page.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH website-transition notice appears above the 403 error page, and the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the previous study record content with an error screen. This blocks access to the study's details, locations, and contact information.SummaryDifference18%

- Check60 days agoChange DetectedThe page's revision tag updated from v3.6.6 to v3.7.0. This reflects a new version of the page being published.SummaryDifference0.0%

Stay in the know with updates to UNCOVER-1 Psoriasis Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UNCOVER-1 Psoriasis Treatment Clinical Trial page.